Literature DB >> 3119054

Bacterial contamination of home nebuliser.

K L Barnes1, R Clifford, S T Holgate, D Murphy, P Comber, E Bell.   

Abstract

Mesh:

Year:  1987        PMID: 3119054      PMCID: PMC1247857          DOI: 10.1136/bmj.295.6602.812

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  3 in total

1.  Microbial contamination of domiciliary nebuliser therapy equipment.

Authors:  P D Jones; V Moritz; R J Pierce
Journal:  Aust N Z J Med       Date:  1985-10

2.  Serratia marcescens infections from inhalation therapy medications: nosocomial outbreak.

Authors:  C V Sanders; J P Luby; W G Johanson; J A Barnett; J P Sanford
Journal:  Ann Intern Med       Date:  1970-07       Impact factor: 25.391

3.  Bronchoconstrictor properties of preservatives in ipratropium bromide (Atrovent) nebuliser solution.

Authors:  C R Beasley; P Rafferty; S T Holgate
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-09
  3 in total
  12 in total

1.  Bacterial colonisation of humidifier attachments on oxygen concentrators prescribed for long term oxygen therapy: a district review.

Authors:  N Pendleton; J S Cheesbrough; M J Walshaw; C R Hind
Journal:  Thorax       Date:  1991-04       Impact factor: 9.139

2.  A national survey of nebuliser use.

Authors:  H J Childs; C A Dezateux
Journal:  Arch Dis Child       Date:  1991-11       Impact factor: 3.791

3.  Nebulised antibiotics for adults with cystic fibrosis.

Authors:  A K Webb; M E Dodd
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

4.  Nebulizer therapy. Guidelines. British Thoracic Society Nebulizer Project Group.

Authors: 
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

5.  Adverse reactions to the non-drug constituents of nebuliser solutions.

Authors:  R Beasley; P Rafferty; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1988-03       Impact factor: 4.335

6.  Bacterial reservoirs in cystic fibrosis.

Authors:  C J Taylor; J McGaw; R Howden; B I Duerden; P S Baxter
Journal:  Arch Dis Child       Date:  1990-02       Impact factor: 3.791

7.  Home-use nebulizers: a potential primary source of Burkholderia cepacia and other colistin-resistant, gram-negative bacteria in patients with cystic fibrosis.

Authors:  G R Hutchinson; S Parker; J A Pryor; F Duncan-Skingle; P N Hoffman; M E Hodson; M E Kaufmann; T L Pitt
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

8.  Control of infection in general practice.

Authors: 
Journal:  BMJ       Date:  1988 Aug 20-27

Review 9.  The epidemiology and therapy of airflow limitation in the elderly.

Authors:  L Dow
Journal:  Drugs Aging       Date:  1992 Nov-Dec       Impact factor: 3.923

10.  Safety of daily albuterol in infants with a history of bronchospasm: a multi-center placebo controlled trial.

Authors:  James A Hedrick; James W Baker; Arthur B Atlas; Aftab A Naz; William R Lincourt; Roopa Trivedi; Anna Ellworth; Angela M Davis
Journal:  Open Respir Med J       Date:  2009-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.